In September 2020, ICER published the white paper: “Cornerstones of ‘Fair’ Drug Coverage: Appropriate Cost-Sharing and Utilization Management Policies for Pharmaceuticals.” This paper analyzes the ethical and practical dimensions of insurance coverage policy, while presenting a corresponding set of criteria that will support a more transparent discussion among all health care stakeholders about whether specific policies are delivering “fair” patient access to prescription drugs.

Building on the criteria discussed within that paper, ICER convened a multi-stakeholder working group — consisting of representatives from leading patient advocacy groups, clinical societies, pharmacy benefit managers, and the life sciences industry— to advise ICER on this annual initiative to assess Barriers to Fair Access within the prescription drug coverage policies of major US payers. 

For questions or additional information, please contact Meaghan Cummings, Special Assistant to the President, at